OnabotulinumtoxinA for treatment of chronic migraine: Results from the double-blind, randomized, placebo-controlled phase of the PREEMPT 1 trial

Aurora, SK; Dodick, DW; Turkel, CC; DeGryse, RE; Silberstein, SD; Lipton, RB; Diener, HC; Brin, MF

doi:10.1177/0333102410364676

Public

OnabotulinumtoxinA for treatment of chronic migraine: Results from the double-blind, randomized, placebo-controlled phase of the PREEMPT 1 trial

Published in Cephalalgia • Mar 17, 2010

Authors:

SK Aurora

DW Dodick

CC Turkel

Abstract

OBJECTIVES: This is the first of a pair of studies designed to assess efficacy, safety and tolerability of onabotulinumtoxinA (BOTOX) as headache prophylaxis in adults with chronic migraine. METHODS: The Phase III REsearch Evaluating Migraine Prophylaxis Therapy 1 (PREEMPT 1) is a phase 3 study, wit...

Subject

Medicine

Migraine

Chronic Migraine

Research Assistant

AI chat, annotations, notes & similar papers

Finding related papers...

Discussions

(0)

No comments yet

Be the first to share your thoughts!